Biotage® (STO: BIOT), announces the launch of Biotage® ACT (Anti Cross Talk) Plate Adapter, an innovative solution for prevention of well to well cross contamination during extract evaporation.
Uppsala, Sweden — Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, announces the launch of Biotage® ACT (Anti Cross Talk) Plate Adapter, an innovative solution for prevention of well to well cross contamination during extract evaporation.
Biotage® ACT Plate Adapter is an essential accessory for evaporation devices. Constructed from robust, high grade anodized aluminum, it fits on top of the 96-well collection plate containing the sample during evaporation. The plate adapter is compatible with straight needle evaporation devices such as the Biotage® SPE Dry 96 and Biotage® SPE Dry Dual systems, and does not require any changes to the existing analytical method.
The Biotage® ACT Plate Adapter is designed to fit on top of the 96-well collection plate, is reusable and easy to use. Evaporated gases are directed away from the sample wells, eddies are reduced, and the plate adapter reduces the open surface area of the top of the wells, lessening the likelihood that material can re-enter and contaminate adjacent wells.
“During evaporation a proportional amount of analytes present in an extracted sample can contaminate surrounding wells by being carried with the volatilized solvent. If the analyte concentration in one well is considerably higher than the analyte concentration in the surrounding wells it has the potential to cause a clinically significant and erroneous change to the adjacent samples. Biotage® ACT Plate Adapter is the first commercially available device to address the issue of cross talk on evaporation” says Dr. Claire Desbrow, Product Manager, Analytical Chemistry, Biotage.
The plate adapter can be incorporated into existing assays without the need for changing any other aspects of the method, and there is minimal impact of solvent drying times.
For further information, visit http://www.biotage.com or call:
In Europe: +46 18 56 57 10
In North America: (Toll Free) 1 800 446 4752
In Japan: +81 422 28 1233
Other areas, please call: +46 18 56 57 10
For further press information at Biotage, please contact:
Biotage GB Limited
Dyffryn Business Park
Hengoed, Wales CF82 7TS
Tel: +44 (0)1443 811 849
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 293 employees with sales of 490 MSEK in 2014. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: http://www.biotage.com.